This scoping review maps machine learning models predicting outcomes in osteosarcoma, suggesting advancements in clinical application.
This scoping review aims to map the available literature regarding the use of imaging-based machine learning (ML) models in patients with osteosarcoma. Specifically, we will investigate models developed to predict clinical outcomes (e.g., survival, metastasis, chemotherapy response) and identify biomarkers. We will also assess the methodological quality and clinical readiness of these studies using the Radiomics Quality Score 2.0 (RQS 2.0) framework and its Radiomics Readiness Levels (RRLs)
No takes yet. Share an insight, caveat, or question.
童浩 (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: